Day: May 3, 2022

Nautilus Biotechnology Reports First Quarter 2022 Financial Results

Written by Customer Service on May 3, 2022. Posted in Earnings Releases And Operating Results.

SEATTLE, May 03, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis, today reported financial results for the first quarter ended March 31, 2022. Recent HighlightsShared a manuscript titled “Development of highly dense and scalable single protein arrays for single-molecule studies” that demonstrates an important element of creating high quality, high-density, single-molecule protein arrays that allow massively parallel detection and identification. Shared results from our research collaboration with Genentech at the annual meeting of the US Human Proteome Organization in a poster titled ‘Single-Molecule Detection of Isoform-Specific Tau Phosphorylation’. Presented a poster at the American Association of Cancer Research’s annual meeting including...

Radware Reports 10% Revenue Growth for The First Quarter 2022

Written by Customer Service on May 3, 2022. Posted in Earnings Releases And Operating Results.

First Quarter 2022 Results and Financial HighlightsRevenue of $73.7 million, up 10% year–over–year Non-GAAP gross margin of 83.2% compared to 82.4% in the first quarter of last year Non-GAAP operating income of $9.6 million, an increase of 28% year–over–year Non-GAAP EPS of $0.19; GAAP EPS of $0.08TEL AVIV, Israel, May 03, 2022 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, today announced its consolidated financial results for the first quarter ended March 31, 2022. “We are excited to report strong first quarter results with double-digit revenue and income growth that was fueled by our cloud and subscription business,” said Roy Zisapel, Radware’s president and CEO. “We made great progress executing on our cloud initiative. We just...

Correction: Form 8.3 – Ideagen

Written by Customer Service on May 3, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Investec Wealth & Investment Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeIdeagen(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Mineworx Pilot Plant Optimization Underway

Written by Customer Service on May 3, 2022. Posted in Public Companies.

EDMONTON, Alberta, May 03, 2022 (GLOBE NEWSWIRE) — Mineworx Technologies Ltd., (the “Company” or “Mineworx“) (TSXV: MWX) (OTCQB: MWXRF) (FSE: YRS WKN: A2DSW3) is pleased to announce that the Company has completed all initial system checks and procedures for its catalytic converter pilot plant in Johnson City, Tennessee. Water testing protocols through the entire system have been completed while checking for system leaks and areas of weakness in the pipes and fittings. All new components are performing as per specifications and all safety and operational protocols are in place. Different types, quantities and grades of catalytic converter feedstock materials, as well as blending of these materials, will be processed over ongoing trial periods. The objective is to accumulate real time data from smaller to...

Release date of three-month interim report (Q1) 2022 for ALK and audio cast

Written by Customer Service on May 3, 2022. Posted in Public Companies.

On Thursday, 12 May 2022, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its three-month interim report (Q1) 2022. ALK will host a meeting for analysts and institutional investors that day at 1.30 pm (CEST) at which Management will review the financial results, the outlook and answer questions. The meeting will be audio cast live on our website https://ir.alk.net, where the related presentation will be available shortly before the meeting begins. Participants in the conference call are kindly requested to call in before 1.25 pm (CEST). Danish participants should call in on tel. +45 3544 5577 and international participants should call in on tel. +44 333 300 0804 or +1 631 913 1422. Please use the following participant pin code: 67379541# ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel....

WEST DRILLS BROAD COPPER-GOLD INTERCEPTS ON THE KENA PROPERTY, BC

Written by Customer Service on May 3, 2022. Posted in Public Companies.

Vancouver, B.C., May 03, 2022 (GLOBE NEWSWIRE) — West Mining Corp. (“West” or the “Company”) (CSE: WEST) (OTC: WESMF) is pleased to announce the analytical results from their initial seven diamond drill holes on the Kena Copper Zone area of its 100% owned Kena Gold and Copper Project in southeastern British Columbia. All 7 holes intercepted strong zones of alteration and silicification along with variable pyrite-chalcopyrite mineralization throughout. The diamond drill holes targeted copper-gold porphyry style mineralization in the Kena Copper Zone, readily identified by a 2,500 x 1,000 metre strong copper soil geochemical anomaly. The Kena Property hosts a large porphyry system consisting of a gold rich core surrounded by a broad halo with a copper-gold signature, as illustrated by the gold and copper soil geochemical maps below. Figure...

Enedo Plc Publishes Business review January 1 – March 31, 2022 – Turnaround program proceeding according to plan but the cash constraints remain

Written by Customer Service on May 3, 2022. Posted in Earnings Releases And Operating Results.

ENEDO PLC Business Review May 3rd, 2022 klo 9:45Enedo Plc Publishes Business review January 1 – March 31, 2022 – Turnaround program proceeding according to plan but the cash constraints remainBusiness Review figures are unaudited. January-March 2022 highlightsNet sales increased by 18% vs same period LY, and amounted to EUR 10,4 million (EUR 8,8 million). Ebitda was positive with EUR 0,8 million (EUR -0,5 million), an increase of EUR 1,3 million. Operating profit on break-even, EUR 0,0 million (EUR -1,3). Net profit for the period was EUR -0,3 million (EUR – 1,6 million). Order intake increased by 13% vs same period LY, and was EUR 14,7 million (EUR 13,0 million). Orderbook at the end of Q1 2022 was EUR 34,1 million (EUR 14,0 million). Turnaround program executed, savings in operative expenditures EUR 0,7 million...

Hybrid Software Group Releases Q1 Results in Line With Last Year

Written by Customer Service on May 3, 2022. Posted in Earnings Releases And Operating Results.

PRESS RELEASE – REGULATED INFORMATION HYBRID SOFTWARE GROUP RELEASES Q1 RESULTS IN LINE WITH LAST YEAR Cambridge (UK) 03 May 2022 (08.00 CEST) – Hybrid Software Group PLC (Euronext: HYSG) provides a trading update for the three months ended 31 March 2022. Mike Rottenborn, CEO comments, “The first quarter of 2022 saw strong sales in the Printing Software and Enterprise Software segments, which helped offset a downturn in Printhead Solutions revenue due to the global shortage of electronic components. Our top-notch engineering team quickly redesigned one of our key products to use more readily available components, and we expect to make up this shortfall in Q2 and throughout the rest of the year. The strategic acquisition of iC3D was completed in March 2022 so it had little impact on the Q1 operating results. “Group EBITDA was down...

Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update

Written by Customer Service on May 3, 2022. Posted in Earnings Releases And Operating Results.

Phase 3 ENHANCE-2 trial on target to report top-line COPD data in Q3 2022 James Brady joined the Board as Non-Executive Director Conference call today at 9:00 a.m. EDT / 2:00 p.m. BST LONDON and RALEIGH, N.C., May 03, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended March 31, 2022, and provides a corporate update. “During the first quarter, enrollment in our Phase 3 ENHANCE (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) clinical program continued and we are now close to completing recruitment for this program,” said David Zaccardelli, Pharm. D., President and Chief Executive Officer. “As of May 2, 2022, approximately 90% of subjects were randomized...

Interim Financial Report of Jyske Realkredit A/S, Q1 2022

Written by Customer Service on May 3, 2022. Posted in Earnings Releases And Operating Results.

To NASDAQ Copenhagen A/S 3 May 2022 Announcement No. 57/2022 Interim Financial Report of Jyske Realkredit A/S, Q1 2022 On May 2, 2022 the Supervisory Board has approved the Interim Financial Report of Jyske Realkredit A/S, Q1 2022. Please see attached file. Yours sincerely,Jyske Realkredit A/S Carsten Tirsbæk MadsenCEO Direct phone (+45) 89 89 90 50E-mail: ctm@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial Report of Jyske Realkredit, Q1 2022.pdfAttachmentInterim Financial Report of Jyske Realkredit...

Day: May 3, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice